Literature DB >> 10367754

Omeprazole does not alter plasma methotrexate clearance.

J Whelan, D Hoare, P Leonard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367754     DOI: 10.1007/s002800050949

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  6 in total

Review 1.  Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors.

Authors:  Shewit Bezabeh; Ann Corken Mackey; Paul Kluetz; Dilara Jappar; Joyce Korvick
Journal:  Oncologist       Date:  2012-04-03

Review 2.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

Review 3.  Effect of proton pump inhibitors on high-dose methotrexate elimination: a systematic review and meta-analysis.

Authors:  Xi Wang; Yanqin Song; Jingjing Wang; Jin He; Ruming Liu; Xiaosu Li; Hua Huang; Jun Zhang
Journal:  Int J Clin Pharm       Date:  2020-01-08

4.  Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy.

Authors:  Kunihiro Suzuki; Kosuke Doki; Masato Homma; Hirofumi Tamaki; Satoko Hori; Hisakazu Ohtani; Yasufumi Sawada; Yukinao Kohda
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

5.  Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report.

Authors:  Tiene G M Bauters; Joris Verlooy; Hugo Robays; Geneviéve Laureys
Journal:  Pharm World Sci       Date:  2008-04-04

6.  Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors.

Authors:  David J Reeves; Elizabeth S Moore; Devon Bascom; Brandon Rensing
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.